Financial Performance Overview

Zota Health Care Limited reported audited financial results for Q4 FY26 and full year FY26 ended March 31, 2026. The company demonstrated significant growth across key financial metrics.

Consolidated Financial Results (₹ in Lakhs)

Revenue from Operations:

  • Q4 FY26: ₹16,317.53
  • Q3 FY26: ₹14,295.14
  • Q4 FY25: ₹9,727.45
  • FY26: ₹53,865.75 (83.86% YoY growth from ₹29,297.46 in FY25)

Revenue Breakdown FY26:

  • Export Sales (SEZ): ₹3,471.09
  • Davaindia Sales: ₹41,741.47
  • Domestic Sales: ₹6,794.29
  • Everyday Herbal Group: ₹1,846.33
  • Others: ₹12.57

Gross Profit:

  • Q4 FY26: ₹10,355.82 (63.46% margin)
  • Q3 FY26: ₹8,617.82 (60.28% margin)
  • Q4 FY25: ₹4,940.00 (50.78% margin)
  • FY26: ₹32,468.90 (108.57% YoY growth from ₹15,567.13 in FY25)
  • Gross Margin: 60.28% in FY26 (714 bps expansion from 53.13% in FY25)

EBITDA:

  • Q4 FY26: ₹1,191.18 (7.30% margin)
  • Q3 FY26: ₹127.57 (0.89% margin)
  • Q4 FY25: ₹346.80 (3.57% margin)
  • FY26: ₹2,597.73 (4.82% margin, improved from negative ₹366.51 in FY25)

Operational Highlights

Davaindia Retail Network Expansion:

  • Total stores as of March 31, 2026: 2,579 (1,656 COCO + 923 FOFO)
  • Q4 FY26 store additions: 248 stores (218 COCO + 30 FOFO)
  • FY26 store additions: 997 stores (804 COCO + 193 FOFO)
  • Represents highest store addition in pharma retail segment in a single financial year

Q4 FY26 Business Metrics:

  • Quarterly footfall: 55.07 lakhs (39.80 lakhs COCO + 15.27 lakhs FOFO)
  • Quarterly GMV: ₹14,035 lakhs (₹9,324 lakhs COCO + ₹4,711 lakhs FOFO)
  • Average wallet spend: ₹235 (COCO), ₹309 (FOFO)

FY26 Business Metrics:

  • Yearly footfall: 182.47 lakhs (126.69 lakhs COCO + 55.78 lakhs FOFO)
  • Yearly GMV: ₹45,706 lakhs (₹29,335 lakhs COCO + ₹16,371 lakhs FOFO)
  • Average wallet spend: ₹232 (COCO), ₹293 (FOFO)

Strategic Initiatives

Brand Ambassador Appointment:

  • Appointed Mr. Akshay Kumar as brand ambassador for Company and "UGO Generic" platform
  • UGO Generic operated through wholly owned subsidiary M/s KMHP Ventures Limited
  • Platform aims to deliver high-quality, affordable medicines through hybrid B2B and B2C model
  • Targets ~12.5 lakh retail pharmacies network nationwide

New Retail Format Launch:

  • Launched "All Day Stores" (ADS) through Everyday Herbal Beauty Care Limited (EHBCL)
  • Offers wide portfolio of private label products across personal care, household essentials, cosmetics, OTC, ayurvedic, surgical, and nutraceutical categories
  • Over 430 SKUs per store

Stake Increase in EHBCL:

  • Increased stake in Everyday Herbal Beauty Care Limited to 87.78%
  • Acquired 1,18,00,000 equity shares via rights issue
  • Investment of ₹19.47 crore at ₹16.50 per share
  • Reinforces backward integration strategy and enhances control over consumer business

Management Commentary

Mr. Ketan Kumar Zota, Chairman, commented on FY26 performance:

  • FY26 was a defining year marked by strong execution and accelerated expansion
  • Scaled presence to 2,579 stores with significant increase in customer footfalls and GMV
  • Strengthened foundation through successful completion of ₹350 crore QIP
  • Expanded into new growth avenues with 'All Day Stores' and 'UGO Generic'
  • Association with brand ambassadors Akshay Kumar, Suniel Shetty, and M.S. Dhoni
  • Long-term vision of reaching 5,000 Davaindia stores by FY29
  • Commitment to making high-quality, affordable healthcare accessible across India

Company Background

Zota Health Care Ltd. (ZOTA) listed on NSE, established in 2000

Headquartered in Surat with over 520 professionals

Specializes in development, manufacturing, and marketing of pharmaceutical, ayurvedic, nutraceutical, and OTC products

Operates through three divisions: marketing, export, and retail pharmacy chain (Davaindia)

Davaindia offers over 2,000 SKUs of quality medicines with backward and forward integration

Renowned for innovative Research and Development team